Longevity PapersAbout
← All papers
RESEARCH PAPER / 2025-08-15

Immunoinflammation and post-translational modifications in the aging process.

Jiaqi Xiao, Xuan Qin, WenTao Chen, Xinyu Que, Yaoyao Ma, Wentao Huang, Haoxiang Ou, Yongfen Bao, Lihua Qu, Shigang Shan

Hubei Key Laboratory of Diabetes and Angiopathy, School of Pharmacy, Hubei University of Science and Technology, Xianning, 437000, China. · pubmed

Abstract

Aging is an intrinsic biological decline marked by multidimensional alterations spanning molecular, cellular, tissue, and organ levels. One hallmark of aging is the progressive deterioration of immune function, a condition referred to as immunosenescence. This process often involves a persistent, mild, and non-infectious inflammatory state across the body, commonly described as inflammaging. The regulation of age-related immune and inflammatory processes is critically influenced by epigenetic mechanisms, such as alterations in DNA methylation patterns, histone modifications, chromatin structure reorganization, and the regulatory actions of non-coding RNAs. Recent research has increasingly focused on the regulatory roles of post-translational modifications (PTMs), including histone methylation, acetylation, ubiquitination, and O-GlcNAcylation, have been widely recognized as fundamental modulators of immunoinflammatory processes in aging. In this review, we provide a comprehensive overview of histone modification-mediated mechanisms involved in the regulation of immunosenescence. We further highlight their functional roles from the perspective of immune inflammation and explore potential therapeutic strategies targeting histone modifications to mitigate immunosenescence.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper discusses the role of post-translational modifications in regulating immunosenescence and inflammation associated with aging. This research is relevant as it addresses mechanisms that contribute to the aging process and explores potential therapeutic strategies to mitigate age-related immune decline.

Author of this paper? Send a correction.